Enhancing Clinical Trials through Risk-Based Quality Management: Upcoming Webinar by Xtalks

Join us for an informative webinar where we will examine how a well-defined risk-based quality management (RBQM) strategy can enhance the quality and efficiency of clinical development programmes. Participants will gain insights into the metrics that underscore the necessity for increased adoption of RBQM, as well as the fundamental components of a successful RBQM strategy. The session will also highlight the importance of central monitoring and its essential function in clinical research.

TORONTO, March 25, 2026 /PRNewswire/ — Risk-based quality management (RBQM) has emerged as a crucial element in the execution of modern clinical trials, enabling sponsors to proactively manage risks to improve data integrity, patient safety, and operational efficiency. The uptake of RBQM in the industry has seen significant progress; data from the Association of Clinical Research Organizations (ACRO) indicates that in 2024, 96% of trials included at least one component of risk-based monitoring (RBM) or RBQM. However, advancing to the next level necessitates the implementation of a comprehensive RBQM strategy that employs fully integrated, cross-functional approaches, which varies across the sector.

This webinar will delve into how sponsors can construct sustainable RBQM frameworks that transcend mere compliance to deliver measurable, long-term value. Attendees will learn about the core attributes of effective RBQM strategies, the evolving role and impact of central monitoring, and real-world outcomes from a case study assessing central monitoring. The session will also discuss prevalent implementation challenges and practical methodologies for enhancing RBQM tailored to the specific needs of various studies.

Register now to discover how a robust and intentional RBQM strategy can lead to superior quality and more efficient clinical development programmes.

Join Dmitri Berman, Vice President of Global Clinical Operations at Premier Research, for the live webinar on Thursday, April 16, 2026, at 11am EDT (5pm CEST/EU-Central).

For further information or to register for this event, please visit the Advancing RBQM Strategy for Greater Impact and Stronger Trials webpage.

ABOUT XTALKS
Xtalks — The Life Science Community™ provides professionals across the pharmaceutical, biotechnology, medical technology, healthcare, and research sectors with the trusted knowledge and collaborative insights necessary for industry advancement. Powered by Honeycomb Worldwide Inc., Xtalks offers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities, and more, all aimed at facilitating informed decision-making in a rapidly evolving landscape.

Each year, numerous professionals depend on Xtalks for timely intelligence, peer perspectives, and thought leadership within the industry. Become part of our life science community to remain informed, connected, and prepared for future developments.

To learn more about Xtalks, visit www.xtalks.com.